首页> 外文期刊>Trends in pharmacological sciences >Historical review: A brief history and personal retrospective of seven-transmembrane receptors.
【24h】

Historical review: A brief history and personal retrospective of seven-transmembrane receptors.

机译:历史回顾:七跨膜受体的简要历史和个人回顾。

获取原文
获取原文并翻译 | 示例
           

摘要

Pharmacologists have studied receptors for more than a century but a molecular understanding of their properties has emerged only during the past 30-35 years. In this article, I provide a personal retrospective of how developments and discoveries primarily during the 1970s and 1980s led to current concepts about the largest group of receptors, the superfamily of seven-transmembrane (7TM) receptors [also known as G-protein-coupled receptors (GPCRs)]. Significant technical advances such as the development of methods for radioligand binding, solubilization and purification of the beta(2)-adrenoceptor and other adrenoceptors led to the cloning of receptor genes and the discovery of their 7TM architecture and homology with rhodopsin. A universal mechanism of receptor regulation by G-protein-coupled receptor kinases (GRKs) and arrestins, originally discovered as a means of 'desensitizing' G-protein-mediated second-messenger generation, was subsequently found to mediate both receptor endocytosis and activation of a growing list of signaling pathways such as those involving mitogen-activated protein kinases. Numerous opportunities for novel therapeutics should emerge from current and future research on 7TM receptor biology.
机译:药理学家对受体的研究已有一个多世纪的历史,但是对分子的特性的分子了解仅在过去30-35年间才出现。在本文中,我将回顾一下主要是在1970年代和1980年代的发展和发现如何导致有关最大受体群的最新概念,即七跨膜(7TM)受体的超家族[也称为G蛋白偶联受体(GPCR)]。重大的技术进步,例如放射性配体结合方法的开发,β(2)-肾上腺素能受体和其他肾上腺素能受体的增溶和纯化,导致了受体基因的克隆以及它们7TM结构和视紫红质同源性的发现。 G蛋白偶联受体激酶(GRKs)和抑制蛋白调节受体的普遍机制,最初被发现是“脱敏” G蛋白介导的第二信使生成的一种手段,后来被发现既能介导受体的内吞作用又能介导细胞的活化。越来越多的信号通路,例如涉及丝裂原活化蛋白激酶的信号通路。当前和未来对7TM受体生物学的研究应会为新型疗法带来许多机遇。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号